Brief: Medexus Provides A Business Update And Outlines Response To Covid-19 Pandemic

Medexus Pharmaceuticals

23/03/2020 13:37

March 23 (Reuters) - Medexus Pharmaceuticals Inc  MDP.V :
    * MEDEXUS PROVIDES A BUSINESS UPDATE AND OUTLINES RESPONSE
TO
COVID-19 PANDEMIC
    * MEDEXUS PHARMACEUTICALS INC - EXPECTS THAT COVID-19 WILL
RESULT
IN MEANINGFUL DELAYS IN ENROLLMENT OF PEDIATRIC TRIAL FOR
IXINITY
    * MEDEXUS PHARMACEUTICALS INC - REVENUE GROWTH IS LIKELY
UNATTAINABLE THIS FISCAL YEAR
    * MEDEXUS PHARMACEUTICALS INC - BELIEVES IMPACT OF COVID-19
ON ITS
PRESCRIPTION DRIVEN BUSINESS WILL BE LIMITED
    * MEDEXUS PHARMACEUTICALS INC - EXPECTS DELAY IN IXINITY
PEDIATRIC
TRIAL TO ENHANCE NEAR TERM CASH FLOW
    * MEDEXUS PHARMACEUTICALS INC - COMPLETED A REDUCTION IN ITS
WORK
FORCE AT TIME OF ITS ACQUISITION OF IXINITY

Source text for Eikon:  ID:nGNX2GMXJg 
Further company coverage:  MDP.V 

 (((Reuters.Briefs@thomsonreuters.com);))